Skip to main content
. 2013 Jan 7;11:6. doi: 10.1186/1479-5876-11-6

Table 3.

Comparison of clinical factors with CXCL14 for stage I/II patients and stage III/IV patients

Clinical Factors
CXCL14 Expression (stage I/II)
CXCL14 Expression (stage III/IV)
  Low (n = 9) High (n = 22) P value Low (n = 68) High (n = 67) P value
Sex
 
 
0.599
 
 
0.543
Female
27 (29.7%)
10 (11.0%)
 
34 (25.2%)
37 (27.4%)
 
Male
42 (46.2%)
12 (13.2%)
 
34 (25.2%)
30 (22.2%)
 
Age
 
 
0.878
 
 
0.878
Mean ± SD
62.4 ± 13.5
63.7 ± 14.1
 
58.7 ± 14.7
59.5 ± 14.0
 
Median
65
64
 
61
62
 
Range
25–88
35–82
 
25–84
29–88
 
TNM stage
 
 
0.674
 
 
0.165
p I
7 (7.7%)
1 (1.1%)
 
 
 
 
p II
62 (68.1%)
21 (23.1%)
 
 
 
 
p III
 
 
 
66 (48.9%)
61 (45.2%)
 
p IV
 
 
 
2 (1.5%)
6 (4.4%)
 
Tumor invasion
 
0.123
 
 
 
0.522
pT1
1 (1.1%)
0 (0%)
 
 
 
 
pT2
6 (6.6%)
1 (1.1%)
 
2 (1.5%)
2 (1.5%)
 
pT3
59 (64.8%)
18 (19.8%)
 
64 (47.4%)
61 (45.2%)
 
pT4
3 (3.3%)
3 (3.3%)
 
2 (1.5%)
4 (3.0%)
 
Lymph node No./metastasis
 
0.348
 
 
 
0.78
0-7/pN0
20 (22.0%)
5 (5.5%)
 
2 (1.5%)
6 (4.4%)
 
8–12/pN1
37 (40.7%)
12 (13.2%)
 
56 (41.5%)
49 (36.3%)
 
>12/pN2
12 (13.2%)
5 (5.5%)
 
10 (7.4%)
12 (8.9%)
 
Grade
 
 
0.246
 
 
0.05
Well
21 (23.1%)
7 (7.7%)
 
20 (14.8%)
9 (6.7%)
 
Moderate
42 (46.2%)
8 (8.8%)
 
44 (32.6%)
46 (34.1%)
 
Poor
6 (6.6%)
7 (7.7%)
 
4 (3.0%)
12 (8.9%)
 
Tumor size, cm
 
0.001
 
 
 
0.002
<2
20 (22.0%)
0 (0%)
 
26 (19.3%)
11 (8.1%)
 
2-5
45 (49.5%)
18 (19.8)
 
34 (25.2%)
38 (28.1%)
 
>5
4 (4.4%)
4 (4.4%)
 
8 (5.9%)
18 (13.3%)
 
Location
 
 
0.100
 
 
0.191
Colon
27 (29.7%)
13 (14.3%)
 
34 (25.2%)
41 (30.4%)
 
Rectum 42 (46.2%) 9 (9.9%)   34 (25.2%) 26 (19.3%)  

Fisher’s exact test; t test; Nonparametric correlations; χ2 test.